Release: Prototype Red Tail Instrument Generates Great Results

Oct 26, 2009. In the acceptance testing of the Red Tail prototype it was determined that the unit 
generated approximately 5 wavenumber resolution which exceeded the design specification of 10
wavenumber. When asked "what difference does this make?" CEO Todd Blonshine responds "To
the technically savvy person this is a very good performance from a reasonably priced Raman
spectrometer. But since our chief market will be users who only really care about getting the
answer they need from their process this aspect of the development work will be somewhat lost.
In their case they can be assured that the instrument has enough power to do more than what the
average user will need."

Release: Preventing Drug Product Recalls is an MTI Goal

May 4, 2010.  Mustard Tree Instruments, LLC, a Cary, North Carolina technology start up,
announces that its Red Tail product may prevent future recalls like the Children’s Tylenol
by Johnson & Johnson Healthcare’s McNeil Pharmaceuticals division. Red Tail is a new Raman
Process Analytical instrument technology that can perform qualitative and quantitative chemical
analysis as products are being manufactured.  Monitoring the active ingredient in liquid drug
formulations is one of the target areas for Red Tail.   Mustard Tree’s CEO, Todd Blonshine comments
“In today’s global economy where raw materials come from all corners of the world, it is more
important than ever to monitor the purity of what is being made. With Mustard Tree tools our customers
can have real time confidence in the composition and quality of their products.”  Founded in May
2009 to develop and market niche analytical solutions for the pharmaceutical manufacturing industry,
Mustard Tree Instruments expects to deliver its first PAT instrument in the fourth quarter of 2010.